![Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy - Al‐Katib - 2020 - Clinical Case Reports - Wiley Online Library Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy - Al‐Katib - 2020 - Clinical Case Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/22bd05c0-88c4-40e9-a758-4902ddd27ac3/ccr33019-fig-0001-m.jpg)
Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy - Al‐Katib - 2020 - Clinical Case Reports - Wiley Online Library
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig1_HTML.jpg)
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
![Frontiers | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype | Immunology Frontiers | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype | Immunology](https://www.frontiersin.org/files/Articles/508073/fimmu-11-00319-HTML/image_m/fimmu-11-00319-g001.jpg)
Frontiers | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype | Immunology
![Frontiers | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype | Immunology Frontiers | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype | Immunology](https://www.frontiersin.org/files/Articles/508073/fimmu-11-00319-HTML/image_m/fimmu-11-00319-g004.jpg)
Frontiers | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype | Immunology
![Cancers | Free Full-Text | Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond | HTML Cancers | Free Full-Text | Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond | HTML](https://www.mdpi.com/cancers/cancers-12-01741/article_deploy/html/images/cancers-12-01741-g001-550.jpg)
Cancers | Free Full-Text | Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond | HTML
![Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy - Al‐Katib - 2020 - Clinical Case Reports - Wiley Online Library Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy - Al‐Katib - 2020 - Clinical Case Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/51d6f296-bfe6-47dc-bf0c-bd34e3869e96/ccr33019-fig-0002-m.jpg)
Emergence of overt myeloma in a patient with chronic lymphocytic leukemia on ibrutinib therapy - Al‐Katib - 2020 - Clinical Case Reports - Wiley Online Library
![Paraprotein–Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias | American Society of Nephrology Paraprotein–Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/11/12/2260/F1.large.jpg?width=800&height=600&carousel=1)
Paraprotein–Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias | American Society of Nephrology
![Quantification of β region IgA paraproteins – should we include immunochemical “heavy/light chain” measurements? Counterpoint Quantification of β region IgA paraproteins – should we include immunochemical “heavy/light chain” measurements? Counterpoint](https://www.degruyter.com/document/doi/10.1515/cclm-2015-0692/asset/graphic/j_cclm-2015-0692_fig_002.jpg)
Quantification of β region IgA paraproteins – should we include immunochemical “heavy/light chain” measurements? Counterpoint
![The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253815302039-gr1.jpg)
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
![Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M‐Proteins) in dogs with multiple myeloma and related disorders: Part 1 – Current performance - Moore - 2021 - Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M‐Proteins) in dogs with multiple myeloma and related disorders: Part 1 – Current performance - Moore - 2021 -](https://onlinelibrary.wiley.com/cms/asset/304fc0ed-2d31-4f26-a65e-f3b8f4814d48/vcp12993-fig-0001-m.jpg)
Diagnostic performance of routine electrophoresis and immunofixation for the detection of immunoglobulin paraproteins (M‐Proteins) in dogs with multiple myeloma and related disorders: Part 1 – Current performance - Moore - 2021 -
![Combination Chemotherapy of Advanced Chronic Lymphocytic Leukemia: The M-2 Protocol (Vincristine, BCNU, Cyclophosphamide, Melphalan, and Prednisone) - ScienceDirect Combination Chemotherapy of Advanced Chronic Lymphocytic Leukemia: The M-2 Protocol (Vincristine, BCNU, Cyclophosphamide, Melphalan, and Prednisone) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120845753-gr3.jpg)
Combination Chemotherapy of Advanced Chronic Lymphocytic Leukemia: The M-2 Protocol (Vincristine, BCNU, Cyclophosphamide, Melphalan, and Prednisone) - ScienceDirect
![Prognostic significance of serum monoclonal immunoglobulin in B-chronic lymphocytic leukemia El-Hussiny MA, Ibrahim L, Azmy E, Shamaa S - Egypt J Haematol Prognostic significance of serum monoclonal immunoglobulin in B-chronic lymphocytic leukemia El-Hussiny MA, Ibrahim L, Azmy E, Shamaa S - Egypt J Haematol](https://www.ehj.eg.net/articles/2012/37/4/images/EgyptJHaematol_2012_37_4_240_134971_3.jpg)
Prognostic significance of serum monoclonal immunoglobulin in B-chronic lymphocytic leukemia El-Hussiny MA, Ibrahim L, Azmy E, Shamaa S - Egypt J Haematol
![Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-020-0295-4/MediaObjects/41408_2020_295_Fig1_HTML.png)
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
![Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction - ScienceDirect Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468024921000012-fx1.jpg)
Diagnostic Approach to Glomerulonephritis With Fibrillar IgG Deposits and Light Chain Restriction - ScienceDirect
![Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias](https://www.degruyter.com/document/doi/10.1515/cclm-2015-0580/asset/graphic/j_cclm-2015-0580_fig_001.jpg)
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
![Frontiers | Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia | Immunology Frontiers | Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia | Immunology](https://www.frontiersin.org/files/Articles/738915/fimmu-12-738915-HTML/image_m/fimmu-12-738915-g001.jpg)